Claritas Pharmaceuticals Inc V.CLAS.H

Moderna’s Safety and Immunogenicity Study NOT COMPLETE

[WORKINMONTANA]

https://clinicaltrials.gov/ct2/show/results/NCT04283461?term=mRNA-1273&cond=Covid19&draw=2&rank=1Trial record 1 of 8 for:    mRNA-1273 | Covid19

Previous Study | Return to List | Next Study

Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

 

ClinicalTrials.gov Identifier: NCT04283461

Recruitment Status  : Active, not recruiting

First Posted  : February 25, 2020

Last Update Posted  : March 12, 2021

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID) 

Collaborator:

ModernaTX, Inc.

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

 

• Study Details
• Tabular View
• No Results Posted
• Disclaimer
• How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status  :	Active, not recruiting
Estimated  Primary Completion Date  :	November 22, 2022
Estimated  Study Completion Date  :	November 22, 2022

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):